 AUSTIN, Texas, Sept. 08, 2021 GLOBE NEWSWIRE -- TFF Pharmaceuticals, Inc. NASDAQ: TFFP, a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing TFF technology platform, today announced that President and CEO Glenn Mattes will present a corporate overview at 23rd H.C. Wainwright Annual Global Investment Conference being held from September 13-15th, 2021. 